We believe we can shorten the time of introducing the emerging technologies to medical society guidelines and clinical practices in the favor of quality of medical services improving the health, quality of life, and patients satisfaction level
Medical technology is advancing at a rapid way, at the same time we face a large and growing gap between the capacity of inventors and scientists to develop innovative solutions and the capacity of health care systems and organizations to fully advance these innovations and incorporate them into actual patients treatment.
We would like to offer our services and support to local organizations of patients dissatisfied with their current treatment options and not having access to the existing innovative medical technologies with clinically proven enhanced treatment value.
We are also ready to support local medical associations and partners from medical technology sectors, like pharmaceuticals, biotechnology, genomics, medical devices and information technology, in their efforts towards discovering, developing and implementing innovative medical technology.
Vast majority of our team members have medical background, so we share the same passion to deliver value adding innovations to available treatment options. We always prioritize patients need and put it as a top priority in our business endeavour.
Our medical background help us better understand health care issues, problems and opportunities, and let us leverage our communication with medical community to higher level of understanding and collaborations.
We base our activity on human resources who played an important roles in top tier international pharmaceutical and medical device organizations and having proven ability to consistently hits business targets. That let us ensure a highest level of efficiency and quality of our work.
The founder of the Pro Arte Medica Ltd is Krzysztof J. Dziedzic, a passionate medical doctor, a holder of the diploma of the Management of the Health Care Organizations of postgraduate study at the Warsaw School of Economics and senior-level professional with extensive experience in business management.
His professional experience has encompasses over 15 years of clinical practice in anesthesiology, intensive care, pain management and emergency medicine and over 17 years of progressively responsible experience in business management, incl. over 10 years of work at senior level positions for leading international corporations, as a Managing Director, Market Company President, Regional Manager and as a member of the Core Executive EU/ME Leadership Team.
All team members are highly competent individuals in different aspects of business management like: pre-launching market profiling and evaluation, market access management, marketing & sales management, building effective distribution system, clinical affairs, safety and medical affairs, HR management, client relationship management incl. collaboration with thought opinion leaders.
Technology alone is not enough, collaboration and knowledge sharing across professional networks from a range of disciplines and point of views create optimal environment for driving innovative med tech and solutions
We facilitate the process of building the communication and collaboration linkage between inventors from academic research community and other stakeholders engaged in development of innovative medical technology. We believe that the informal relations and interactions between particular parties will be transformed into common project development plans.
We are ready to take a role of coordinator of entire process from project initiation to it’s delivery, ensuring cost conscious approach and orientation on results achievement on the assumed time frame.
We support individual inventors, scientific organizations, and pharma start-up companies, especially involved in basic discovery research, early and late-stage drug candidates and pre-commercial stage candidates, by making a positive contribution towards optimization of drug development and commercialization process.
We facilitate capital raising efforts through assisting our clients in initial and advanced search for untraditional sources of financing, besides those offered by banking sector, venture capitals and business angels.
We provide outsourcing services related to R&D activities, incl. preclinical pharmacology services for early proof-of-concept of therapeutics, implementation of RCTs on competitive terms as well as to application of marketing approvals accordingly to EMA and FDA agencies requirements.
Defining this critical decision making elements we are ready to supply our partners with a road map for potential new product launch and geographic expansion. Our outsourced activities save our partners financial and human resources and prevent organization against distracting their current operational focus.
At the same time parallel proactive investigations can bring the opportunity for business development and maximization of innovation solutions implementation momentum.
We provide our industry partners with key data critically important in decision making on potential launch of new med tech into Polish / EEU market as: preliminary, customized market potential analysis with growth perspective across particular markets, current treatment practices, KOL’s initial feedback to new value enhanced solution, evidence needs and market access requirements, pricing and reimbursement rules, pre-launch forecasting, sales and distribution models, general costs of direct market presence.
We are ready to support our customers in building a strategic market entry plan, including OPEX requirements, as well as to cooperate with them in development of strategic market access documents like reimbursement dossier, HTA strategy, pricing strategy with risk-sharing approach.
We believe that involving different health care market players and building informal networks and task alliances through collective thinking, and working together we can lower barriers to adopting new innovative medical technologies and influence the time of their availability to patients.
We facilitate process of translating new scientifically and clinically proven, innovative treatment solution knowledge into new products / courses of enhanced treatment value, to be produced and marketed for clinical daily use through building strong educational foundation with ensured quality of scientific informations and clarity of messages.
We want not only to build favorable conditions for implementation around new emerging technology / invention but also to form alliances for it’s incorporation into practice. Our role is motivating and supporting collaborative working between different players involved in health care market improvements, implementation of innovations and advancing patients access to new technologies.